Skip to main content
. Author manuscript; available in PMC: 2022 Jul 7.
Published in final edited form as: Exp Eye Res. 2020 Jul 4;198:108135. doi: 10.1016/j.exer.2020.108135

Figure 5.

Figure 5.

Post symptomatic intravitreal rhTPP1 halted decline of retinal cone responses in CLN2-affected dogs. Intravitreal injections #1 and #2 were given within 1 week following the Baseline #1 and #2 ERG measurements, respectively. Data from normal (n=7) and CLN2-affected (n=6) untreated dogs are historical data obtained from Dachshunds from the same research colony.